Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma

Identifying novel prognostic biomarkers for hepatocellular carcinoma (HCC) and then, develop an effective individualized treatment strategy remain extremely warranted. The prognostic role of sulfiredoxin‐1(SRXN1), an antioxidant enzyme, remains unknown in HCC. This study aimed to explore the prognos...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Qian‐Wen, Zhang, Shi‐Long, Guo, Meng‐Zhou, Yuan, Fei‐Fei, Sun, Jia‐Lei, Qi, Feng, Wang, Li‐Shun, Yang, Bi‐Wei, Xia, Jing‐Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666720/
https://www.ncbi.nlm.nih.gov/pubmed/32955798
http://dx.doi.org/10.1002/cam4.3430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666720/
https://www.ncbi.nlm.nih.gov/pubmed/32955798
http://dx.doi.org/10.1002/cam4.3430

Ejemplares similares